Related Experiment Videos
New side effect of the hypoxic cell sensitizer, misonidazole
Cancer Treatment Reports
|January 1, 1979
Summary
Misonidazole, a radiosensitizer, caused skin hypersensitivity in two patients during a phase II study. Re-challenging with the drug confirmed it as the cause of the dermatitis, indicating a drug-related adverse reaction.
Area of Science:
- Oncology
- Pharmacology
- Dermatology
Background:
- Phase II clinical trial investigating misonidazole as a hypoxic cell radiosensitizer.
- Misonidazole is a nitroimidazole drug used to enhance the efficacy of radiation therapy.
Observation:
- Two patients in the study developed dermatitis.
- The skin reactions reappeared upon re-administration of misonidazole after drug withdrawal.
Findings:
- The observed dermatitis was a drug-related hypersensitivity reaction to misonidazole.
- This suggests a specific immune response to the radiosensitizer.
Implications:
- Highlights the potential for skin hypersensitivity as an adverse effect of misonidazole.
- Informs clinical practice regarding patient monitoring for dermatological reactions during misonidazole therapy.